Global mortality associated. With 33 bacterial pathogens in 2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2022;400(10369):2221–48.

Article  Google Scholar 

Kopotsa K, Osei Sekyere J, Mbelle NM. Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann N Y Acad Sci. 2019;1457(1):61–91.

Article  PubMed  Google Scholar 

Heng H, Yang X, Ye L, Tang Y, Guo Z, Li J, Chan EW, Zhang R, Chen S. Global genomic profiling of Klebsiella pneumoniae: a spatio-temporal population structure analysis. Int J Antimicrob Agents. 2024;63(2):107055.

Article  PubMed  Google Scholar 

Wang J, Feng Y, Zong Z. Worldwide transmission of ST11-KL64 carbapenem-resistant Klebsiella pneumoniae: an analysis of publicly available genomes. mSphere. 2023;8(4):e0017323.

Article  PubMed  Google Scholar 

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–96.

Article  PubMed  PubMed Central  Google Scholar 

Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46.

Article  PubMed  Google Scholar 

Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, et al. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis. 2015;15(2):225–34.

Article  PubMed  Google Scholar 

Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589–601.

Article  PubMed  Google Scholar 

Binsker U, Käsbohrer A, Hammerl JA. Global colistin use: a review of the emergence of resistant enterobacterales and the impact on their genetic basis. FEMS Microbiol Rev 2022, 46(1).

Huang YH, Chou SH, Liang SW, Ni CE, Lin YT, Huang YW, Yang TC. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan. J Antimicrob Chemother. 2018;73(8):2039–46.

Article  PubMed  Google Scholar 

Kaur A, Gandra S, Gupta P, Mehta Y, Laxminarayan R, Sengupta S. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a single-center retrospective study of 75 cases in India. Am J Infect Control. 2017;45(11):1289–91.

Article  PubMed  Google Scholar 

Koppe U, von Laer A, Kroll LE, Noll I, Feig M, Schneider M, Claus H, Eckmanns T, Abu Sin M. Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrob Resist Infect Control. 2018;7:71.

Article  PubMed  PubMed Central  Google Scholar 

Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG et al. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States. Antimicrob Agents Chemother 2017, 61(4).

Kopotsa K, Mbelle NM, Osei Sekyere J. Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant Klebsiella pneumoniae clinical strains. Microb Genom 2020, 6(12).

Shankar C, Jacob JJ, Sugumar SG, Natarajan L, Rodrigues C, Mathur P, Mukherjee DN, Sharma A, Chitnis DS, Bharagava A, et al. Distinctive Mobile genetic elements observed in the Clonal expansion of Carbapenem-resistant Klebsiella pneumoniae in India. Microb Drug Resist. 2021;27(8):1096–104.

Article  PubMed  Google Scholar 

Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and Resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–96.

Article  PubMed  PubMed Central  Google Scholar 

Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–703.

Article  PubMed  PubMed Central  Google Scholar 

Ding Y, Hao J, Xiao W, Ye C, Xiao X, Jian C, Tang M, Li G, Liu J, Zeng Z. Role of efflux pumps, their inhibitors, and regulators in colistin resistance. Front Microbiol. 2023;14:1207441.

Article  PubMed  PubMed Central  Google Scholar 

Liu JH, Liu YY, Shen YB, Yang J, Walsh TR, Wang Y, Shen J. Plasmid-mediated colistin-resistance genes: mcr. Trends Microbiol. 2024;32(4):365–78.

Article  PubMed  Google Scholar 

CLSI. Performance standards for antimicrobial susceptibility testing, 31st ed. CLSI Supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2021.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

Article  PubMed  Google Scholar 

Feng Y, Zou S, Chen H, Yu Y, Ruan Z. BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking. Nucleic Acids Res. 2021;49(D1):D644–50.

Article  PubMed  Google Scholar 

Hadjirin NF, van Tonder AJ, Blane B, Lees JA, Kumar N, Delappe N, Brennan W, McGrath E, Parkhill J, Cormican M et al. Dissemination of carbapenemase-producing enterobacterales in Ireland from 2012 to 2017: a retrospective genomic surveillance study. Microb Genom 2023, 9(3).

Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014;44(6):500–7.

Article  PubMed  Google Scholar 

Berglund B, Hoang NTB, Tärnberg M, Le NK, Svartström O, Khu DTK, Nilsson M, Le HT, Welander J, Olson L, et al. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam. Int J Antimicrob Agents. 2018;51(5):789–93.

Article  PubMed  Google Scholar 

Kong Y, Li C, Chen H, Zheng W, Sun Q, Xie X, Zhang J, Ruan Z. In vivo emergence of Colistin Resistance in Carbapenem-resistant Klebsiella pneumoniae mediated by premature termination of the mgrB Gene Regulator. Front Microbiol. 2021;12:656610.

Article  PubMed  PubMed Central  Google Scholar 

McLaughlin MM, Advincula MR, Malczynski M, Barajas G, Qi C, Scheetz MH. Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC Infect Dis. 2014;14:31.

Article  PubMed  PubMed Central  Google Scholar 

Russo TA, Olson R, Fang CT, Stoesser N, Miller M, MacDonald U, Hutson A, Barker JH, La Hoz RM, Johnson JR. Identification of biomarkers for differentiation of Hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 2018, 56(9).

Li G, Shi J, Zhao Y, Xie Y, Tang Y, Jiang X, Lu Y. Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with Galleria mellonella infectivity. Eur J Clin Microbiol Infect Dis. 2020;39(9):1673–9.

Article  PubMed  Google Scholar 

Lin L, Xiao X, Wang X, Xia M, Liu S. In Vitro Antimicrobial susceptibility differences between Carbapenem-resistant KPC-2-Producing and NDM-1-Producing Klebsiella pneumoniae in a Teaching Hospital in Northeast China. Microb Drug Resist. 2020;26(2):94–9.

Article  PubMed  Google Scholar 

Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2023 Guidance on the treatment of Antimicrobial resistant gram-negative infections. Clin Infect Dis 2023.

Rodríguez-Medina N, Rodríguez-Santiago J, Alvarado-Delgado A, Sagal-Prado A, Silva-Sánchez J, De la Cruz MA, Ares MA, Sánchez-Arias M, Morfín-Otero R, Hernández-Castro R, et al. Comprehensive study reveals phenotypic heterogeneity in Klebsiella pneumoniae species complex isolates. Sci Rep. 2024;14(1):5876.

Article  PubMed  PubMed Central  Google Scholar 

da Silva KE, Baker S, Croda J, Nguyen TNT, Boinett CJ, Barbosa LS, Tetila A, Simionatto S. Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: an epidemiological and clinical study. Int J Antimicrob Agents. 2020;55(3):105882.

Article  PubMed  Google Scholar 

Sodhi K, Mittal V, Arya M, Kumar M, Phillips A, Kajla B. Pattern of colistin resistance in Klebsiella isolates in an Intensive Care Unit of a tertiary care hospital in India. J Infect Public Health. 2020;13(7):1018–21.

Article  PubMed  Google Scholar 

Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307–12.

Article  PubMed  Google Scholar 

Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S. Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106.

Article  PubMed  PubMed Central  Google Scholar 

Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147. Antimicrob Agents Chemother 2020, 64(10).

Hu F, Pan Y, Li H, Han R, Liu X, Ma R, Wu Y, Lun H, Qin X, Li J, et al. Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study. Nat Microbiol. 2024;9(3):814–29.

Article  PubMed